Trial watch: Dendritic cell-based interventions for cancer therapy
Dendritic cells (DCs) occupy a central position in the immune system, orchestrating a wide
repertoire of responses that span from the development of self-tolerance to the elicitation of …
repertoire of responses that span from the development of self-tolerance to the elicitation of …
Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy
P Yang, M Meng, Q Zhou - Biochimica et Biophysica Acta (BBA)-Reviews …, 2021 - Elsevier
Increasing evidence shows that numerous cancer-testis antigens (CTAs) are uniquely
overexpressed in various types of cancer and most CTAs are oncogenic. Overexpression of …
overexpressed in various types of cancer and most CTAs are oncogenic. Overexpression of …
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information
C Montero-Conde, JM Martin-Campos, E Lerma… - Oncogene, 2008 - nature.com
Undifferentiated and poorly differentiated thyroid tumors are responsible for more than half
of thyroid cancer patient deaths in spite of their low incidence. Conventional treatments do …
of thyroid cancer patient deaths in spite of their low incidence. Conventional treatments do …
Clinical benefit of allogeneic melanoma cell lysate–pulsed autologous dendritic cell vaccine in MAGE-positive colorectal cancer patients
Purpose: We evaluated the clinical benefit of an allogeneic melanoma cell lysate (MCL)–
pulsed autologous dendritic cell (DC) vaccine in advanced colorectal cancer patients …
pulsed autologous dendritic cell (DC) vaccine in advanced colorectal cancer patients …
An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members
MF Gjerstorff, HJ Ditzel - Tissue antigens, 2008 - Wiley Online Library
GAGE cancer/testis antigens are frequently expressed in many different types of cancer,
whereas their expression in normal tissues is limited to the germ cells of the immune …
whereas their expression in normal tissues is limited to the germ cells of the immune …
Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine
SK Burgdorf, A Fischer, PS Myschetzky… - Oncology …, 2008 - spandidos-publications.com
Patients with disseminated colorectal cancer have a poor prognosis. Preliminary studies
have shown encouraging results from vaccines based on dendritic cells. The aim of this …
have shown encouraging results from vaccines based on dendritic cells. The aim of this …
Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions
J Berry, T Vreeland, A Trappey, D Hale… - Expert review of …, 2017 - Taylor & Francis
Introduction: Great advances have been made in screening for and treatment of colorectal
cancer (CRC), but recurrence rates remain high and additional therapies are needed. There …
cancer (CRC), but recurrence rates remain high and additional therapies are needed. There …
Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination
SK Burgdorf, MH Claesson, HJ Nielsen… - Acta …, 2009 - Taylor & Francis
Introduction. Immunotherapy based on dendritic cell vaccination has exciting perspectives
for treatment of cancer. In order to clarify immunological mechanisms during vaccination it is …
for treatment of cancer. In order to clarify immunological mechanisms during vaccination it is …
[PDF][PDF] Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study.
Tumor lysate-pulsed dendritic cell injections were well-tolerated in all patients with no more
than grade 1 injection-related toxicity. Local inflammatory response was mainly …
than grade 1 injection-related toxicity. Local inflammatory response was mainly …
Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy
Cancer-germline antigens are promising targets for cancer immunotherapy, but whether
such therapies will also eliminate the primary tumor stem cell population remains …
such therapies will also eliminate the primary tumor stem cell population remains …